| 000 | 01556 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517160637.0 | ||
| 264 | 0 | _c20180319 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a1478-6362 | ||
| 024 | 7 |
_a10.1186/s13075-017-1330-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSolomon, Daniel H | |
| 245 | 0 | 0 |
_aDrug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurement. _h[electronic resource] |
| 260 |
_bArthritis research & therapy _c06 2017 |
||
| 300 |
_a130 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aConfounding Factors, Epidemiologic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfections _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOutcome Assessment, Health Care _xmethods |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aRegistries _xstatistics & numerical data |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aShadick, Nancy A | |
| 700 | 1 | _aWeinblatt, Michael E | |
| 700 | 1 | _aZak, Agnes | |
| 700 | 1 | _aFrits, Michelle | |
| 700 | 1 | _aFranklin, Jessica M | |
| 773 | 0 |
_tArthritis research & therapy _gvol. 19 _gno. 1 _gp. 130 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13075-017-1330-0 _zAvailable from publisher's website |
| 999 |
_c27273997 _d27273997 |
||